期刊文献+

FFJ-5下调PKM2抑制MCF7生长及逆转MCF7/DOX细胞耐药性的研究 被引量:3

FFJ-5 inhibits growth of MCF7 cells and reverses drug resistance of MCF7 / DOX cells via down-regulation of PKM2
下载PDF
导出
摘要 目的探讨FFJ-5对人乳腺癌细胞MCF7及其耐药细胞MCF7/DOX的作用及其机制。方法采用MTT法检测FFJ-5对MCF7及MCF7/DOX细胞的增殖抑制作用及其对柔红霉素(doxorubicin,DOX)在耐药细胞MCF7/DOX中化疗敏感性的影响;Western blot检测FFJ-5对EGFR、p-EGFR、Akt、p-Akt、PKM2、caspase-3、cleaved caspase-3、PARP、cleaved PARP及P-gp蛋白表达的影响;DNA ladder分析检测FFJ-5对细胞基因组DNA的影响;RT-PCR检测低剂量FFJ-5对多药耐药基因MDR1 mRNA水平的影响。结果 FFJ-5抑制了MCF7细胞生长,降低了MCF7细胞中EGFR、Akt的表达及活性,下调了PKM2水平;FFJ-5可激活caspase-3、促使基因组DNA断裂;同时FFJ-5也能抑制耐药细胞MCF7/DOX生长,并增强DOX在MCF7/DOX细胞中的活性,同时降低了MCF7/DOX细胞中EGFR、p-EGFR及PKM2水平,但对MDR1 mRNA水平无影响。结论 FFJ-5可通过抑制EGFRAkt-PKM2通路及激活线粒体凋亡相关因子caspase-3来抑制MCF7细胞生长,并诱导其凋亡,并可逆转MCF7/DOX的耐药性。 Aim To investigate the roles of FFJ-5 in human breast cancer MCF7 cells and drug-resistant MCF7/DOX cells and to explore its mechanisms. Methods MTT assay was used to detect the effect of FFJ-5 on MCF7 and MCF7/DOX cell proliferation and sensitivity of doxorubicin in MCF7/DOX cells.West-ern blot was used to investigate the effect of FFJ-5 on expression of EGFR,p-EGFR,Akt,p-Akt,PKM2, cleaved caspase-3,cleaved PARP and P-gp.DNA lad-der analysis was performed to determine the effect of FFJ-5 on genomic DNA.RT-PCR was performed to de-tect the influence of FFJ-5 on multidrug resistance gene MDR1 mRNA levels.Results The results showed that FFJ-5 inhibited the growth of MCF7 ,inhibited the expression and activity of EGFR and Akt,and conse-quently reduced the expression of PKM2 in MCF7 cells;FFJ-5 activated caspase-3 and induced genomic DNA fragmentation;FFJ-5 also inhibited the growth of MCF7/DOX cells and enhanced the anti-tumor activity of doxorubicin in MCF7/DOX cells.Conclusion The results suggest that FFJ-5 could inhibit MCF7 cell growth and induce MCF7 cell apoptosis through inhibi-tion of EGFR-Akt-PKM2 pathway and activation of ap-optosis-related factors caspase-3 , meanwhile FFJ-5 could also reverse the resistance of MCF7/DOX.
出处 《中国药理学通报》 CAS CSCD 北大核心 2015年第5期721-726,共6页 Chinese Pharmacological Bulletin
基金 河南省科技厅重点攻关项目(No 122102310558) 河南省教育厅自然科学研究项目(No 2011A310001)
关键词 FFJ-5 丙酮酸激酶M2 EGFR AKT 细胞凋亡 细胞耐药性 信号通路 FFJ-5 PKM2 EGFR Akt cell apopto-sis drug resistant cells cell signal pathway
  • 相关文献

参考文献13

  • 1Xu Q, Liu X, Zheng X, et al. PKM2 regulates Glil expression in hepatocellular carcinoma[ J ]. Oncol Lett, 2014,8 (5) : 1973 - 9.
  • 2Iqbal M A, Gupta V, Gopinath P, et al. Pyruvate kinase M2 and cancer: an updated assessment[ J]. FEBS Lett, 2014,588 (16) : 2685 - 92.
  • 3Yang W, Zheng Y, Xia Y, et al. ERK1/2-dependent phosphoryl- ation and nuclear translocation of PKM2 promotes the Warburg effect[J]. Nat Cell Biol, 2012, 14(12) :1295 -304.
  • 4Liu J, Wu N, Ma L, et al. Oleanolic acid suppresses aerobic gly- colysis in cancer cells by switching pyruvate kinase type M isoforms [J]. PLoS One, 2014,9(3) :e91606.
  • 5陈昆仑,刘莹,李明利,高艳娥,高庆.PTEN通过AKT介导的细胞代谢途径抑制宫颈癌细胞的增殖[J].西安交通大学学报(医学版),2013,34(5):563-567. 被引量:10
  • 6Shilpa P N, Sivaramakrishnan V, Niranjali Devaraj S. Induction of apeptosis by methanolic extract of Rubia cordifolia Linn in HEp-2 cell line is mediated by reactive oxygen species[J]. As/an Pac J Cancer Prev, 2012,13 (6) :2753 -8.
  • 7Shilpa P N, V S, Devaraj S N. Ameliora- tive effect of methanol extract of Rubia cordifolia in N-nitrosodieth- ylamine-induced hepatocellular carcinoma [ J ]. Pharm Biol, 2012, 50 (3) :376 -83.
  • 8Alessandro A, Christian W. Glucose metabolism in cancer cells [J]. Curt Opin Clin Nutr Metab Care, 2010, 13:(4) 466 -70.
  • 9Guido K, Jacques P. Tumor cell metabolism: cancer's Achilles' heel[J]. Cancer Cell, 2008, 13(6) : 472 -82.
  • 10Kaelin W G Jr, Thompson C B. Q&A: Cancer: clues from cell metabolism[ J]. Nature, 2010, 465('/298) : 562-4.

二级参考文献10

  • 1DI CRISTOFANO A, PESCE B, CORDON-CARDO C, et al. Pten is essential for embryonic development and tumour sup- pression[J]. Nat Genet, 1998, 19(4):348-355.
  • 2LI J, YEN C, LIAW D, et al. PTEN, a putative protein tyro- sine phosphatase gene mutated in human brain, breast, and prostate cancer[J]. Science, 1997, 275(5308):1943-1947.
  • 3NESHAT MS, MELLINGHOFF IK, TRAN C, et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR [J]. PNAS, 2001, 98(18):10314-10319.
  • 4LEE JS, CHOI YD, LEE JH, et al. Expression of PTEN in the progression of cervical neoplasia and its relation to tumor be- havior and angiogenesis in invasive squamous cell carcinoma [J]. J Surg Oncol, 2006, 93(3),233-240.
  • 5CARNERL A, BLANOCO-APARICIO C, RENNER O, et al. The PTEN/PI3K/AKT signalling pathway in cancer, therapeu- tic implications[J]. Curt Cancer Drug Targets, 2008, 8 (3) : 187-198.
  • 6ZONCU R, EFEYAN A, SABATINI DM. mTOR: from growth signal integration to cancer, diabetes and ageing[J]. Nat Rev Mol Cell Biol, 2011, 12(1):21-35.
  • 7COLOMBO SL, PALACIOS-CALLENDER M, FRAKICH N, et al. Anaphase-promoting cornplex/cyclosome-Cdhl coordi- nates glycolysis and glutarninolysis with transition to Sphase in human T lymphocytes[J]. Proc Natl Acad Sci USA, 2010, 107 (44) :18868-18873.
  • 8SONG MS, CARRACEDO A, SALMENA L, et al. NucLear PTEN regulates the APC-CDH1 tumorsuppressive complex in a phosphatase-independent manner[J]. Cell, 2011, 144(2):187- 199.
  • 9彭秋平,梁后杰.糖酵解代谢在恶性肿瘤细胞中的特异性表型及其意义[J].临床肿瘤学杂志,2009,14(5):470-473. 被引量:22
  • 10孟红梅,王文波,李锁严,杨薇薇,徐丽,陈明,陈鹤.PTEN与HIF-1α在宫颈癌组织中的表达及相关性研究[J].哈尔滨医科大学学报,2011,45(1):46-50. 被引量:2

共引文献9

同被引文献18

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部